Select Medical (NYSE:SEM) Downgraded to "Hold" Rating by Benchmark

Select Medical (NYSE:SEM - Get Free Report) was downgraded by stock analysts at Benchmark from a "buy" rating to a "hold" rating in a report issued on Monday, Marketbeat Ratings reports.

A number of other analysts also recently commented on the company. Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 price objective on the stock. Finally, StockNews.com cut shares of Select Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $40.75.

Select Medical Stock Performance

SEM traded down $0.46 during trading on Monday, reaching $39.21. The company's stock had a trading volume of 422,946 shares, compared to its average volume of 612,184. The company has a market capitalization of $5.08 billion, a price-to-earnings ratio of 18.54, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42. The company's fifty day moving average price is $35.19 and its 200-day moving average price is $35.05. Select Medical has a 52-week low of $22.26 and a 52-week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the business posted $0.46 earnings per share. Select Medical's revenue was up 5.7% compared to the same quarter last year. On average, equities analysts forecast that Select Medical will post 2.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Select Medical

Hedge funds and other institutional investors have recently made changes to their positions in the business. Tidal Investments LLC acquired a new stake in shares of Select Medical in the first quarter worth $467,000. Hood River Capital Management LLC acquired a new position in Select Medical in the second quarter worth $14,819,000. Comerica Bank lifted its holdings in Select Medical by 30.0% in the first quarter. Comerica Bank now owns 68,485 shares of the health services provider's stock worth $2,065,000 after acquiring an additional 15,824 shares during the last quarter. Boston Partners acquired a new position in shares of Select Medical during the first quarter valued at $718,000. Finally, Principal Financial Group Inc. raised its stake in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider's stock valued at $82,208,000 after acquiring an additional 147,032 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company's stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.